Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial

Q. Xiong, Henry; Rosenberg, Arthur; LoBuglio, Albert; Schmidt, William; A. Wolff, Robert; Deutsch, John; Needle, Michael; L. Abbruzzese, James

doi:10.1200/jco.2004.12.040

Public

Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial

Shared by NobleBlocks on Jul 1, 2004 • 12:00 AM UTC

Authors:

Henry Q. Xiong

Arthur Rosenberg

Albert LoBuglio

Abstract

Purpose To determine the response rate, time to disease progression, survival duration and rate, and toxicity with the combination of cetuximab and gemcitabine in patients with epidermal growth factor receptor (EGFR)-expressing advanced pancreatic cancer. Patients and Methods Patients with measurabl...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!